{"entity":{"type":"insider","cik":"0001363812","url":"/insider/0001363812","json_url":"/insider/0001363812.json","name":"Henderson Molly","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":19,"first":"2008-03-17","last":"2025-04-08","span_basis":"filed_date"},"name_variants":[{"name":"Henderson Molly","source":"filing","n_filings":19,"first_seen":"2008-03-17","last_seen":"2025-04-08"}],"transactions":[{"id":4946095,"accession":"0000950170-25-052156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-052156","line_url":"/filing/0000950170-25-052156#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3678.0,"shares_display":"3,678","price_per_share":4.5513,"price_display":"4.55","price_state":"stated","total_value":16739.6814,"total_display":"16,739.68","total_whole":"16,740","shares_owned_after":89868.0,"shares_owned_after_display":"89,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-07","filed_date":"2025-04-08","scope":"insider"},{"id":4415469,"accession":"0000950170-25-008357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-008357","line_url":"/filing/0000950170-25-008357#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6583.0,"shares_display":"6,583","price_per_share":6.5883,"price_display":"6.59","price_state":"stated","total_value":43370.7789,"total_display":"43,370.78","total_whole":"43,371","shares_owned_after":93546.0,"shares_owned_after_display":"93,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":2652126,"accession":"0000950170-24-139062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-139062","line_url":"/filing/0000950170-24-139062#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1291.0,"shares_display":"1,291","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":10328.0,"total_display":"10,328.00","total_whole":"10,328","shares_owned_after":98156.0,"shares_owned_after_display":"98,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2771426,"accession":"0000950170-24-084182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-084182","line_url":"/filing/0000950170-24-084182#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4325.0,"shares_display":"4,325","price_per_share":11.72,"price_display":"11.72","price_state":"stated","total_value":50689.0,"total_display":"50,689.00","total_whole":"50,689","shares_owned_after":99447.0,"shares_owned_after_display":"99,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-17","scope":"insider"},{"id":2825895,"accession":"0000950170-24-043385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-043385","line_url":"/filing/0000950170-24-043385#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stoock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3435.0,"shares_display":"3,435","price_per_share":11.1,"price_display":"11.10","price_state":"stated","total_value":38128.5,"total_display":"38,128.50","total_whole":"38,129","shares_owned_after":95263.0,"shares_owned_after_display":"95,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-10","scope":"insider"},{"id":3170343,"accession":"0001209191-24-002021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-002021","line_url":"/filing/0001209191-24-002021#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6307.0,"shares_display":"6,307","price_per_share":7.7533,"price_display":"7.75","price_state":"stated","total_value":48900.0631,"total_display":"48,900.06","total_whole":"48,900","shares_owned_after":98698.0,"shares_owned_after_display":"98,698","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-19","filed_date":"2024-01-22","scope":"insider"},{"id":8079393,"accession":"0001209191-23-056288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056288","line_url":"/filing/0001209191-23-056288#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2127.0,"shares_display":"2,127","price_per_share":7.2415,"price_display":"7.24","price_state":"stated","total_value":15402.6705,"total_display":"15,402.67","total_whole":"15,403","shares_owned_after":103061.0,"shares_owned_after_display":"103,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-21","scope":"insider"},{"id":7955177,"accession":"0001209191-23-054355","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-054355","line_url":"/filing/0001209191-23-054355","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12492.0,"shares_display":"12,492","price_per_share":8.875340217739353,"price_display":"8.88","price_state":"stated","total_value":110870.75,"total_display":"110,870.75","total_whole":"110,871","shares_owned_after":105188.0,"shares_owned_after_display":"105,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-03","scope":"insider","n_lines":2},{"id":7972351,"accession":"0001209191-23-034605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-034605","line_url":"/filing/0001209191-23-034605#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1960.0,"shares_display":"1,960","price_per_share":11.4121,"price_display":"11.41","price_state":"stated","total_value":22367.716,"total_display":"22,367.72","total_whole":"22,368","shares_owned_after":68506.0,"shares_owned_after_display":"68,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-05","scope":"insider"},{"id":8187915,"accession":"0001209191-23-031647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-031647","line_url":"/filing/0001209191-23-031647#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2110.0,"shares_display":"2,110","price_per_share":12.8744,"price_display":"12.87","price_state":"stated","total_value":27164.984,"total_display":"27,164.98","total_whole":"27,165","shares_owned_after":70466.0,"shares_owned_after_display":"70,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-23","scope":"insider"},{"id":7950371,"accession":"0001209191-23-023749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023749","line_url":"/filing/0001209191-23-023749#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3439.0,"shares_display":"3,439","price_per_share":7.27,"price_display":"7.27","price_state":"stated","total_value":25001.53,"total_display":"25,001.53","total_whole":"25,002","shares_owned_after":72576.0,"shares_owned_after_display":"72,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-07","scope":"insider"},{"id":7994719,"accession":"0001209191-23-016023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016023","line_url":"/filing/0001209191-23-016023#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2032.0,"shares_display":"2,032","price_per_share":8.5309,"price_display":"8.53","price_state":"stated","total_value":17334.7888,"total_display":"17,334.79","total_whole":"17,335","shares_owned_after":76015.0,"shares_owned_after_display":"76,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"},{"id":6497915,"accession":"0001209191-22-058627","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058627","line_url":"/filing/0001209191-22-058627#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2159.0,"shares_display":"2,159","price_per_share":9.6,"price_display":"9.60","price_state":"stated","total_value":20726.4,"total_display":"20,726.40","total_whole":"20,726","shares_owned_after":43341.0,"shares_owned_after_display":"43,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"},{"id":6823536,"accession":"0001209191-22-029446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-029446","line_url":"/filing/0001209191-22-029446#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO and CBO)","role_mark":"O","role_mark_label":"Officer (CFO and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and CBO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":26000.0,"shares_owned_after_display":"26,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-16","scope":"insider"},{"id":6976839,"accession":"0001209191-22-006385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-006385","line_url":"/filing/0001209191-22-006385#line-2","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":331.0,"shares_display":"331","price_per_share":7.58,"price_display":"7.58","price_state":"stated","total_value":2508.98,"total_display":"2,508.98","total_whole":"2,509","shares_owned_after":5248.0,"shares_owned_after_display":"5,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-02-02","scope":"insider"},{"id":4288575,"accession":"0001209191-21-067439","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-067439","line_url":"/filing/0001209191-21-067439#line-2","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2587.0,"shares_display":"2,587","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":31121.61,"total_display":"31,121.61","total_whole":"31,122","shares_owned_after":4913.0,"shares_owned_after_display":"4,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-02","scope":"insider"},{"id":5491432,"accession":"0001209191-21-033402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033402","line_url":"/filing/0001209191-21-033402#line-1","is_derivative":false,"issuer_cik":"0001363812","issuer_name":"UroGen Pharma Ltd.","issuer_ticker":"URGN","issuer_name_source":null,"issuer_url":"/issuer/0001363812","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":15.85,"price_display":"15.85","price_state":"stated","total_value":39625.0,"total_display":"39,625.00","total_whole":"39,625","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-18","scope":"insider"},{"id":2947834,"accession":"0001144204-12-035853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-12-035853","line_url":"/filing/0001144204-12-035853#line-1","is_derivative":false,"issuer_cik":"0001307752","issuer_name":"VirtualScopics, Inc.","issuer_ticker":"VSCP","issuer_name_source":null,"issuer_url":"/issuer/0001307752","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CBFO)","role_mark":"O","role_mark_label":"Officer (CBFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CBFO","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":7200.0,"total_display":"7,200.00","total_whole":"7,200","shares_owned_after":14400.0,"shares_owned_after_display":"14,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-19","filed_date":"2012-06-21","scope":"insider"},{"id":3593382,"accession":"0001144204-08-015793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-08-015793","line_url":"/filing/0001144204-08-015793#line-1","is_derivative":false,"issuer_cik":"0001307752","issuer_name":"VirtualScopics, Inc.","issuer_ticker":"VSCP","issuer_name_source":null,"issuer_url":"/issuer/0001307752","owner_cik":"0001363812","owner_name":"Henderson Molly","owner_display_name":"Henderson Molly","owner_url":"/insider/0001363812","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6440.0,"shares_display":"6,440","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":4379.2,"total_display":"4,379.20","total_whole":"4,379","shares_owned_after":6440.0,"shares_owned_after_display":"6,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-14","filed_date":"2008-03-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001783183","name":"Phathom Pharmaceuticals, Inc.","url":"/issuer/0001783183","role":"Officer (CFO and CBO)","n_filings":14,"first_seen":"2022-05-16","last_seen":"2025-04-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001668243","name":"UroGen Pharma Ltd.","url":"/issuer/0001668243","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2021-05-18","last_seen":"2022-02-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001307752","name":"VirtualScopics, Inc.","url":"/issuer/0001307752","role":"Officer (CBFO)","n_filings":2,"first_seen":"2008-03-17","last_seen":"2012-06-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001363812","retrieved_at":"2026-08-25T10:18:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}